Brooks Moore & Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-18,366
| Closed | -$609K | – | 87 |
|
|
2023
Q3 | $609K | Sell |
18,366
-600
| -3% | -$19.9K | 0.46% | 53 |
|
|
2023
Q2 | $696K | Sell |
18,966
-300
| -2% | -$11K | 0.49% | 52 |
|
|
2023
Q1 | $786K | Buy |
19,266
+3,600
| +23% | +$147K | 0.56% | 50 |
|
|
2022
Q4 | $803K | Buy |
15,666
+862
| +6% | +$44.2K | 0.59% | 45 |
|
|
2022
Q3 | $648K | Sell |
14,804
-75
| -0.5% | -$3.28K | 0.52% | 45 |
|
|
2022
Q2 | $780K | Hold |
14,879
| – | – | 0.56% | 47 |
|
|
2022
Q1 | $770K | Sell |
14,879
-1,398
| -9% | -$72.3K | 0.47% | 57 |
|
|
2021
Q4 | $961K | Sell |
16,277
-201
| -1% | -$11.9K | 0.56% | 46 |
|
|
2021
Q3 | $709K | Sell |
16,478
-187
| -1% | -$8.05K | 0.46% | 58 |
|
|
2021
Q2 | $653K | Buy |
16,665
+513
| +3% | +$20.1K | 0.42% | 62 |
|
|
2021
Q1 | $585K | Buy |
16,152
+2,314
| +17% | +$83.8K | 0.4% | 62 |
|
|
2020
Q4 | $509K | Sell |
13,838
-958
| -6% | -$35.2K | 0.39% | 64 |
|
|
2020
Q3 | $515K | Buy |
14,796
+1,366
| +10% | +$47.5K | 0.44% | 60 |
|
|
2020
Q2 | $417K | Sell |
13,430
-11,841
| -47% | -$368K | 0.39% | 62 |
|
|
2020
Q1 | $783K | Sell |
25,271
-158
| -0.6% | -$4.9K | 0.83% | 41 |
|
|
2019
Q4 | $945K | Sell |
25,429
-2,354
| -8% | -$87.5K | 0.75% | 47 |
|
|
2019
Q3 | $947K | Sell |
27,783
-503
| -2% | -$17.1K | 0.8% | 44 |
|
|
2019
Q2 | $1.16M | Buy |
28,286
+1,526
| +6% | +$62.7K | 1% | 37 |
|
|
2019
Q1 | $1.08M | Buy |
26,760
+530
| +2% | +$21.4K | 0.98% | 38 |
|
|
2018
Q4 | $1.09M | Buy |
+26,230
| New | +$1.09M | 1.09% | 35 |
|